These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 16221540

  • 1. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    Sipahi OR, Arda B, Yurtseven T, Sipahi H, Ozgiray E, Suntur BM, Ulusoy S.
    Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
    [Abstract] [Full Text] [Related]

  • 2. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E, Gul M, Ergun Y, Eroglu E.
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [Abstract] [Full Text] [Related]

  • 3. Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases.
    Arda B, Yamazhan T, Sipahi OR, Islekel S, Buke C, Ulusoy S.
    Int J Antimicrob Agents; 2005 May; 25(5):414-8. PubMed ID: 15848297
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Nagura J, Kijima K, Kurazono M, Takahata S, Sugano T, Tanaka Y, Hirai Y, Yamada K, Takayama Y, Shitara E, Yonezawa M.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
    [Abstract] [Full Text] [Related]

  • 5. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH, Hsu RB.
    Scand J Infect Dis; 2008 Aug; 40(6-7):462-7. PubMed ID: 18584532
    [Abstract] [Full Text] [Related]

  • 6. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
    Gerber P, Stucki A, Acosta F, Cottagnoud M, Cottagnoud P.
    J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
    [Abstract] [Full Text] [Related]

  • 7. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ, Hume EB, Moreau JM, Caballero AR, Cannon BM, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model.
    Conaughty JM, Chen J, Martinez OV, Chiappetta G, Brookfield KF, Eismont FJ.
    Spine (Phila Pa 1976); 2006 Oct 15; 31(22):E830-2. PubMed ID: 17047530
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection.
    Fernández-Hidalgo N, Gavaldà J, Almirante B, Martín MT, Onrubia PL, Gomis X, Pahissa A.
    J Antimicrob Chemother; 2010 Mar 15; 65(3):525-30. PubMed ID: 20083550
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
    Yin LY, Calhoun JH, Thomas TS, Wirtz ED.
    J Antimicrob Chemother; 2009 Feb 15; 63(2):357-60. PubMed ID: 19060292
    [Abstract] [Full Text] [Related]

  • 11. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N, Jacqueline C, Le Mabecque V, Batard E, Bugnon D, Potel G, Caillon J.
    Antimicrob Agents Chemother; 2005 Feb 15; 49(2):857-9. PubMed ID: 15673789
    [Abstract] [Full Text] [Related]

  • 12. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.
    Calik S, Turhan T, Yurtseven T, Sipahi OR, Buke C.
    Med Sci Monit; 2012 Nov 15; 18(11):SC5-8. PubMed ID: 23111752
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.
    Mallaval FO, Carricajo A, Delavenna F, Recule C, Fonsale N, Manquat G, Raffenot D, Rogeaux O, Aubert G, Tous J.
    Clin Microbiol Infect; 2004 May 15; 10(5):459-61. PubMed ID: 15113326
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative efficacy of vancomycin and teicoplanin in the treatment of hospitalised elderly patients with persistent meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia.
    Lin SH, Lai CC, Tan CK, Liao WH, Hsueh PR.
    Int J Antimicrob Agents; 2011 Feb 15; 37(2):179-81. PubMed ID: 21163634
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
    Kohno S, Yamaguchi K, Aikawa N, Sumiyama Y, Odagiri S, Aoki N, Niki Y, Watanabe S, Furue M, Ito T, Croos-Dabrera R, Tack KJ.
    J Antimicrob Chemother; 2007 Dec 15; 60(6):1361-9. PubMed ID: 17913720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.